Francesco Bruno, MD, PhD, discusses early predictors of vorasidenib response, including volumetric MRI, PET, and seizure control, in IDH-mutant glioma.
Francesco Bruno, MD, PhD
Advertisement
Francesco Bruno, MD, PhD, is a neurologist and neuro-oncologist in the Division of Neuro-Oncology in the Department of Neuroscience at the University of Turin and the City of Health and Science University Hospital
Articles by Francesco Bruno, MD, PhD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
Dr Johnson on Immune Activation With Indoximod-Based Chemo-Immunotherapy in Recurrent Ependymoma
2
Tovorafenib Sustains Treatment-Free Intervals in R/R BRAF-Altered Pediatric Low-Grade Glioma
3
Dr Miller on Whole Genome Sequencing of CSF ctDNA in High-Grade Glioma
4
Patient Preferences Steer Decisions as Options Multiply Across EGFR-Mutated NSCLC
5